Figure 2.

Comparison of the proportion of patients (all coagulopathic patients as well as coagulopathic patients surviving more than 48 hours) requiring massive transfusion. Massive transfusion was defined as more than 12 red blood cell (RBC) units within 48 hours of the first dose, which equals more than 20 units of RBCs (inclusive of the 8 pre-dose units) in the placebo and recombinant activated factor VII (rFVIIa) groups.